Mineralys Therapeutics
MLYS
MLYS
164 hedge funds and large institutions have $889M invested in Mineralys Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 76 increasing their positions, 30 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $971M → $889M (-$82.6M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
97% less call options, than puts
Call options by funds: $30K | Put options by funds: $1.11M
Holders
164
Holding in Top 10
9
Calls
$30K
Puts
$1.11M
Top Buyers
| 1 | +$39.2M | |
| 2 | +$12.5M | |
| 3 | +$10.3M | |
| 4 |
BlackRock
New York
|
+$8.76M |
| 5 |
SC
Stempoint Capital
New York
|
+$8.55M |
Top Sellers
| 1 | -$39.2M | |
| 2 | -$10.1M | |
| 3 | -$6.35M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$5.87M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$4.44M |
